Background Delays in performing urgent coronary artery bypass graft (CABG) surgery are increasing across the UK, with ...
Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III ...
Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...
Background Secondary prevention is critical for patients with established atherosclerotic cardiovascular diseases (ASCVD).
Background The limited literature provides minimal information on clinical outcomes among patients undergoing percutaneous coronary intervention (PCI) under different healthcare funding systems, ...
Background Anticoagulation non-adherence is attributed to myriad factors in patient populations across the world. While direct oral anticoagulants (DOACs) have demonstrated several clinical advantages ...
APCU25CR28 Navigating dual diagnosis: case report of amyloid transthyretin (ATTR) cardiac amyloidosis and amyloid light-chain (AL) (13 February, 2026) ...
Introduction Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have revolutionized lipid management, particularly in patients with atherosclerotic cardiovascular disease (ASCVD) and ...
Introduction Athletes with neurological impairments such as cerebral palsy (CP) present unique challenges in cardiovascular screening. Usually, T-wave inversion in leads V1–V4 on an athlete’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results